NIH – Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

May 20, 2022 by


The purpose of this Funding Opportunity Announcement (FOA) is to encourage grant applications for the conduct of scientific research utilizing data from expanded access (EA) for investigational drugs or biological products. These applications will target EA for intermediate size populations of patients living with amyotrophic lateral sclerosis (ALS) who are not eligible for ongoing clinical trials for the prevention, diagnosis, mitigation, treatment, or cure of ALS.

Key Dates:

Open Date (Earliest Submission Date): May 15, 2022
Letter of Intent Due Date(s): May 17, 2022
Applications Due: June 17, 2022

URL for more information:

Filed Under: Funding Opportunities